4.4 Editorial Material

Patents vs patients 1-0: The case of chenodeoxycholic acid

Journal

JOURNAL OF INHERITED METABOLIC DISEASE
Volume 45, Issue 2, Pages 377-378

Publisher

WILEY
DOI: 10.1002/jimd.12443

Keywords

CDCA; cerebrotendinous xanthomatosis; chenodeoxycholic acid; CTX; orphan drug; xanthoma

Ask authors/readers for more resources

Profit-driven games resulted in discontinuation of proper treatment for a patient with cerebrotendinous xanthomatosis, leading to disastrous consequences for his health.
Profit-driven games with the availability and prices of chenodeoxycholic acid led to the discontinuation of proper treatment for this cerebrotendinous xanthomatosis patient with disastrous consequences to his health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available